Akiko Ohshita

发表

Generation of Antigen-Presenting Cells Using Cultured Dendritic Cells and Amplified Autologous Tumor mRNA

K. Ohta, J. Hihara, Y. Yamaguchi, 2005, Oncology.

Enhancing effect of PS-K on IL-2-induced lymphocyte activation: possible involvement of antagonistic action against TGF-beta.

Y. Yamaguchi, A. Ohshita, Y. Kawabuchi, 2004, Anticancer research.

Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.

J. Hihara, Y. Yamaguchi, E. Miyahara, 2004, International journal of oncology.

Host-oriented peptide evaluation using whole blood assay for generating antigen-specific cytotoxic T lymphocytes.

Y. Yamaguchi, A. Ohshita, Y. Kawabuchi, 2004, Anticancer research.

Screening of CEA Epitope Peptide using the Whole Blood Assay

Y. Yamaguchi, A. Ohshita, Y. Kawabuchi, 2003 .

Locoregional immunotherapy of malignant effusion from colorectal cancer using the streptococcal preparation OK-432 plus Interleukin-2

K. Shimizu, K. Ohta, J. Hihara, 2003, British Journal of Cancer.

Feasibility study of adoptive immunotherapy for metastatic lung tumors using peptide-pulsed dendritic cell-activated killer (PDAK) cells.

R. Okita, K. Ohta, Y. Yamaguchi, 2005, Anticancer research.

Generation of tumor-reactive effector lymphocytes using tumor RNA-introduced dendritic cells in gastric cancer patients.

R. Okita, Y. Yamaguchi, A. Ohshita, 2006, International journal of oncology.

Neoadjuvant therapy of rectal cancer using oral tegaful-uracil (UFT) plus concomitant radiotherapy--a case report.

K. Arihiro, M. Emi, Y. Yamaguchi, 2005, Hiroshima journal of medical sciences.

HER2-specific cytotoxic activity of lymphokine-activated killer cells in the presence of trastuzumab.

R. Okita, Y. Yamaguchi, K. Matsuura, 2005, Anticancer research.